Abstract

THERAPEUTIC APPLICATION BROMFENAC, MOXIFLOXACIN AND MOXI-DEXAMETHASONE IN EYE DISORDERS

Parvathi M. L., Rachita Kurmi and Silpa T. S.

ABSTRACT

The purpose of this pooled analysis is to investigate the safety and efficacy of once daily Bromfenac for ocular inflammation and pain among patients after cataract extraction (CE). Bromfenac, a promising ophthalmic non-steroidal anti-inflammatory drug, has been shown to be a safe and effective treatment for postoperative pain and inflammation in subjects undergoing CE. Non-steroidal anti-inflammatory drugs (NSAIDs) inhibit COXs so as to inhibit post- operative pain and inflammation. It is becoming prevalent to begin NSAIDs dosing anywhere from 1–2 days before surgery to reduce postoperative inflammation and pain.

Keywords: .